• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Novanta Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    5/9/24 4:00:25 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous
    Get the next $NOVT alert in real time by email
    8-K
    0001076930false00010769302024-05-082024-05-08

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    FORM 8-K

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): May 8, 2024

    NOVANTA INC.

    (Exact name of registrant as specified in is charter)

    New Brunswick, Canada

    001-35083

    98-0110412

    (State or other jurisdiction

    of incorporation)

    (Commission File Number)

    (IRS Employer

    Identification No.)

     

     

     

    125 Middlesex Turnpike

    Bedford, Massachusetts

    01730

    (Address of principal executive offices)

    (Zip Code)

    Registrant’s telephone number, including area code: (781) 266-5700

    Not Applicable

    (Former name or former address, if changed since last report)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading

    Symbol(s)

     

    Name of each exchange on which registered

    Common shares, no par value

     

    NOVT

     

    Nasdaq Global Select Market

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


     

    Item 5.07. Submission of Matters to Vote of Security Holders

    On May 8, 2024, Novanta Inc. (the “Company”) held its annual general meeting of shareholders (“Annual Meeting of Shareholders”). A total of 33,856,181 common shares were present or represented by proxy at the meeting, representing approximately 94.33 percent of the Company’s outstanding common shares as of March 25, 2024, the record date for the meeting. The following are the voting results on the proposals considered and voted upon at the meeting, all of which were described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 3, 2024.

    Item 1 — Election of directors for a term of office expiring on the date of the Company's next Annual Meeting of Shareholders in 2025, until their successor is elected or appointed, or until their earlier death, resignation, or removal.

    NOMINEE

     

    Votes FOR

     

    Votes WITHHELD

     

    Broker Non-Votes

    Lonny J. Carpenter

     

    32,597,629

     

    429,262

     

    829,290

    Matthijs Glastra

     

    32,195,418

     

    831,473

     

    829,290

    Barbara B. Hulit

     

    32,776,706

     

    250,185

     

    829,290

    R. Matthew Johnson

     

    32,993,659

     

    33,232

     

    829,290

    Maxine L. Mauricio

     

    32,500,223

     

    526,668

     

    829,290

    Katherine A. Owen

     

    32,970,015

     

    56,876

     

    829,290

    Thomas N. Secor

     

    32,482,347

     

    544,544

     

    829,290

    Darlene J. S. Solomon, Ph.D.

     

    32,965,634

     

    61,257

     

    829,290

    Frank A. Wilson

     

    32,899,773

     

    127,118

     

    829,290

    Item 2 — Approval, on an advisory basis, of the Company’s executive compensation.

    Votes FOR

     

    Votes AGAINST

     

    Votes ABSTAINED

     

    Broker Non-Votes

    32,388,395

     

    625,061

     

    13,435

     

    829,290

    Item 3 — Appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm to serve until the Company's next Annual Meeting of Shareholders in 2025.

    Votes FOR

     

    Votes WITHHELD

    33,816,295

     

    39,886

    Based on the foregoing votes, each of the nine nominees for director was elected and Items 2 and 3 were approved.

     

     


     

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

     

    Novanta Inc.

    Date: May 9, 2024

    By:

    /s/ Michele D. Welsh

    Michele D. Welsh

    General Counsel and Corporate Secretary

     

     

     

     


    Get the next $NOVT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NOVT

    DatePrice TargetRatingAnalyst
    3/30/2026$144.00Neutral → Outperform
    Robert W. Baird
    5/11/2022Mkt Perform → Outperform
    William Blair
    More analyst ratings

    $NOVT
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Novanta Inc.

    SCHEDULE 13G/A - NOVANTA INC (0001076930) (Subject)

    3/27/26 11:05:08 AM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 10-K filed by Novanta Inc.

    10-K - NOVANTA INC (0001076930) (Filer)

    2/23/26 4:57:30 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Novanta Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - NOVANTA INC (0001076930) (Filer)

    2/23/26 4:45:25 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    $NOVT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Novanta Inc. Announces Schedule of First Quarter 2026 Earnings Release and Conference Call

    Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2026 results after the close of U.S. financial markets on Monday, May 11, 2026. The Company will host a conference call on Tuesday, May 12, 2026, at 8:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the Events & Presentations page of the Investors section of the Company's website at www.novanta.com. A replay of the audio webcast will be available approximately three hou

    4/14/26 11:00:00 AM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Novanta Joins NVIDIA Halos AI Systems Inspection Lab

    Novanta Inc. (NASDAQ:NOVT) announced today that it has joined NVIDIA Halos AI Systems Inspection Lab, the first ANSI National Accreditation Board (ANAB) accredited inspection lab for AI-driven physical systems. The lab helps accelerate certification and advance trust in key components and subsystems enabling the next generation of robotics and physical AI systems. By participating in Halos AI Systems Inspection Lab, Novanta will work with NVIDIA to validate the interoperability of our motion control and sensing technologies with safety requirements of NVIDIA platforms, including NVIDIA IGX Thor. This collaboration is designed to streamline the adoption of critical technology solutions to

    3/16/26 4:40:00 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Novanta Announces Financial Results for the Fourth Quarter and Full Year 2025

    Fourth Quarter 2025 GAAP Revenue increased 9% to $258 million, and GAAP Diluted EPS was $0.45 Fourth Quarter 2025 Adjusted Diluted EPS was $0.91, increased 20%, and Adjusted EBITDA was $61 million, increased 17% Full Year 2025 GAAP Revenue increased 3% to $981 million, and GAAP Diluted EPS was $1.47 Full Year 2025 Adjusted Diluted EPS was $3.29, and Adjusted EBITDA was $221 million Novanta Inc. (NASDAQ:NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the fourth quarter and full year 2025. Financial Highlights Three Months Ended December 31,    

    2/23/26 4:45:00 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    $NOVT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Buckley Robert

    4 - NOVANTA INC (0001076930) (Issuer)

    3/18/26 4:49:22 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Chief Executive Officer Glastra Matthijs sold $899,239 worth of shares (6,500 units at $138.34), decreasing direct ownership by 9% to 63,261 units (SEC Form 4)

    4 - NOVANTA INC (0001076930) (Issuer)

    3/4/26 4:24:06 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Co-Chief Operating Officer Ravetto Charles Guy Jr converted options into 825 shares and covered exercise/tax liability with 243 shares, increasing direct ownership by 4% to 16,116 units (SEC Form 4)

    4 - NOVANTA INC (0001076930) (Issuer)

    2/26/26 4:14:18 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    $NOVT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Novanta upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded Novanta from Neutral to Outperform and set a new price target of $144.00

    3/30/26 8:13:23 AM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Novanta upgraded by William Blair

    William Blair upgraded Novanta from Mkt Perform to Outperform

    5/11/22 6:19:56 AM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    $NOVT
    Financials

    Live finance-specific insights

    View All

    Novanta Inc. Announces Schedule of First Quarter 2026 Earnings Release and Conference Call

    Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2026 results after the close of U.S. financial markets on Monday, May 11, 2026. The Company will host a conference call on Tuesday, May 12, 2026, at 8:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the Events & Presentations page of the Investors section of the Company's website at www.novanta.com. A replay of the audio webcast will be available approximately three hou

    4/14/26 11:00:00 AM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Novanta Announces Financial Results for the Fourth Quarter and Full Year 2025

    Fourth Quarter 2025 GAAP Revenue increased 9% to $258 million, and GAAP Diluted EPS was $0.45 Fourth Quarter 2025 Adjusted Diluted EPS was $0.91, increased 20%, and Adjusted EBITDA was $61 million, increased 17% Full Year 2025 GAAP Revenue increased 3% to $981 million, and GAAP Diluted EPS was $1.47 Full Year 2025 Adjusted Diluted EPS was $3.29, and Adjusted EBITDA was $221 million Novanta Inc. (NASDAQ:NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the fourth quarter and full year 2025. Financial Highlights Three Months Ended December 31,    

    2/23/26 4:45:00 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 24, 2026

    Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth quarter 2025 results on Tuesday, February 24, 2026. The Company will host a conference call on Tuesday, February 24, 2026, at 8:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the Events & Presentations page of the Investors section of the Company's website at www.novanta.com. A replay of the audio webcast will be available approximately three hours after the conclusion of the

    1/22/26 11:00:00 AM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    $NOVT
    Leadership Updates

    Live Leadership Updates

    View All

    IDEX Corporation Appoints Stephanie Disher and Matthijs Glastra to Board of Directors; David Parry and Livingston Satterthwaite to Retire

    IDEX Corporation (NYSE:IEX) today announced the appointment of Stephanie ("Steph") Disher and Matthijs Glastra to the company's Board of Directors. The appointments, effective Friday, February 21, 2025, increase the size of the Board from 10 to 12 directors. Ms. Disher will serve on the Board's Nominating and Corporate Governance Committee, and Mr. Glastra will serve on the Board's Audit Committee. Ms. Disher currently serves as Chief Executive Officer of Atmus Filtration Technologies Inc. (NYSE:ATMU), a leader in filtration and media solutions. She has extensive global leadership experience in finance and operations from her time at Atmus, Cummins Inc. and BP, p.l.c. Mr. Glastra currentl

    2/20/25 5:07:00 PM ET
    $ATMU
    $IEX
    $NOVT
    Auto Parts:O.E.M.
    Consumer Discretionary
    Fluid Controls
    Industrials

    Politan Details Why a Truly Independent Board is Urgently Needed at Masimo in Order to Protect Shareholder Value and Realize the Company's Full Potential

    Sends Letter to Masimo Shareholders and Releases 160-Page Investor Presentation Urges Shareholders to Help Deliver Immediate Change by Voting for Both of Politan's Independent and Ideally Qualified Nominees Darlene Solomon and William Jellison on the WHITE Card Shareholders Can Visit www.AdvanceMasimo.com for Further Information Politan Capital Management (together with its affiliates, "Politan"), an 8.9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ:MASI), today sent a letter to the Company's shareholders outlining why a majority of truly independent directors are urgently needed in the Masimo boardroom. Politan also released a detailed investor presentation m

    6/26/24 8:00:00 AM ET
    $A
    $ANIK
    $AVNT
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Medical/Dental Instruments
    Health Care

    $NOVT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Novanta Inc.

    SC 13G/A - NOVANTA INC (0001076930) (Subject)

    11/14/24 1:22:36 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G filed by Novanta Inc.

    SC 13G - NOVANTA INC (0001076930) (Subject)

    2/14/24 10:02:59 AM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G/A filed by Novanta Inc. (Amendment)

    SC 13G/A - NOVANTA INC (0001076930) (Subject)

    2/13/24 5:09:44 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous